Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.


Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cochrane Reviews, 10/20/09

Today in Derm Allergy/Immunology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Oral Allergy Syndrome
Allergology International, 10/30/09

High sensitization rate to food allergens in breastfed infants with atopic dermatitis
Annals of Allergy, Asthma, and Immunology, 10/15/09

Today in Rheumatic/Autoimmune...keeping you current

Latent Autoimmune Diabetes in Adults
Journal of Clinical Endocrinology and Metabolism, 10/21/09

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address